SPONSORED CONTENT
Join Verity Solutions for a conversation on the latest policy and operational implications of the IRA and the 340B program with guest speakers Ted Slafsky of 340B Report and Felicity Homsted from FQHC 340B Compliance, moderated by Verity’s Matt Krah.
Landmark legislation allowing the government to negotiate Medicare drug prices was enacted as part of the Inflation Reduction Act (IRA) in 2022. Since then, the government has selected the first ten drugs for negotiation, and many other vital aspects of the law have gone into effect.
In this webinar session, speakers will unravel the IRA’s implications for 340B stakeholders. Our guest speakers will provide an overview of the law, the next steps in implementation, and how the election results could impact this initiative. You will also get an in-depth look at inflationary penalties, negotiated prices, and the financial implications for the 340B community.
This event is open to all 340B stakeholders.
*We appreciate the time you take to be with us. If your organization policy allows, please accept lunch on us! ($15-$20 value). You will have the option to opt-in or out at registration.
Speakers:
Ted Slafsky is the Publisher & CEO of 340B Report, the only news and intelligence service exclusively covering the 340B program. Slafsky, who has over 25 years of leadership experience with the 340B program, is also Founder & Principal of the consulting firm Wexford Solutions. He served as President & CEO of 340B Health and held other senior positions at the organization during his 22-year tenure. He also played a key role in the development of the 340B Coalition, a large group of trade associations representing 340B providers.
Felicity Homsted is Chief Executive Officer for FQHC 340B Compliance LLC. In this role, she works with health centers and hospitals across the country to manage and improve their 340B and pharmacy programs. Previously, Dr. Homsted was Chief Pharmacy Officer for Penobscot Community Health Center, Maine’s largest FQHC. She was responsible for the administration of four pharmacies, integrated pharmacy services and PCHC’s two accredited pharmacy residency programs. She served as Subject Matter Expert for the Apexus 340B Prime Vendor Program, Apexus 340B University Faculty and Apexus 340B Operations Certificate modules author.
Matt Krah, MHA is a 340B expert with nearly two decades of experience in both clinical and business settings. He serves as Sr. Solutions Engagement Director for Verity Solutions, a Seattle-based 340B TPA. Prior to joining Verity as a 340B Program Manager, he gained experience in mixed-use, retail, and specialty contract pharmacy as well as revenue cycle management, making him uniquely suited to serve as a 340B subject matter expert for prospective and existing clients at Verity.
